Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

• Yaxin Chen,
• Lei Xia,
• Yuxuan Peng,
• Gang Wang,
• Liyun Bi,
• Xue Xiao,
• Cui Li,
• Weimin Li,
• Weimin Li,
• Weimin Li,
• Weimin Li

Affiliations

Yaxin Chen

Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China

Lei Xia

Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China

Yuxuan Peng

Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China

Gang Wang

Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China

Liyun Bi

Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China

Xue Xiao

Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China

Cui Li

Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China

Weimin Li

Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China

Weimin Li

Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China

Weimin Li

Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China

Weimin Li

The Research Units of West China, Chinese Academy of Medical Sciences, West China Hospital, Chengdu, China